 |
Microvesiculated modified glycosylated tissue factor |
|---|---|
| Trade Name | |
| Orphan Indication | Non-life threatening, mild to severe bleeding episodes due to cutaneous injuries or dental procedures in patients with von Willebrand disease |
| USA Market Approval | USA |
| USA Designation Date | 2007-10-11 00:00:00 |
| Sponsor | Thrombotargets Corp.;2530 Meridian Parkway;Durham, North Carolina, 27713 |
